The challenges of gene expression microarrays for the study of human cancer
- PMID: 16697954
- DOI: 10.1016/j.ccr.2006.05.001
The challenges of gene expression microarrays for the study of human cancer
Abstract
Large-scale genomic studies promise to advance our understanding of the biology of human cancers and to improve their diagnosis, prognostication, and treatment. The analysis and interpretation of genomics studies have faced challenges. The retrospective and observational design of many studies has rendered them susceptible to confounding and bias. Technological variations and advances have impacted on reproducibility. Statistical hurdles in relating a large number of variables to a small number of observations have added further constraints. This review considers the promise and challenge associated with the large-scale clinically oriented genomic analysis of human cancer and attempts to emphasize potential solutions.
Similar articles
-
Gene microarrays in tumor diagnosis: opportunities and challenges.Med Health R I. 2005 Jul;88(7):212-5. Med Health R I. 2005. PMID: 16184824 No abstract available.
-
Evolving strategies for global gene expression analysis of cancer.J Cell Physiol. 2008 Dec;217(3):590-7. doi: 10.1002/jcp.21554. J Cell Physiol. 2008. PMID: 18680120 Review.
-
Implications of micro-RNA profiling for cancer diagnosis.Oncogene. 2006 Oct 9;25(46):6220-7. doi: 10.1038/sj.onc.1209914. Oncogene. 2006. PMID: 17028602 Review.
-
Implications of oncogenomics for cancer research and clinical oncology.Cancer J. 2001 Jan-Feb;7(1):40-51. Cancer J. 2001. PMID: 11269647 Review.
-
Applications of biochips: from diagnostics to personalized medicine.Curr Opin Drug Discov Devel. 2004 May;7(3):285-9. Curr Opin Drug Discov Devel. 2004. PMID: 15216931 Review.
Cited by
-
Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.Mol Biol Rep. 2010 Dec;37(8):4091-101. doi: 10.1007/s11033-010-0069-3. Epub 2010 Mar 19. Mol Biol Rep. 2010. PMID: 20300861
-
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.Lancet Oncol. 2009 Jul;10(7):663-71. doi: 10.1016/S1470-2045(09)70154-8. Epub 2009 Jun 8. Lancet Oncol. 2009. PMID: 19515614 Free PMC article.
-
CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.Biomed Res Int. 2019 Oct 13;2019:1245072. doi: 10.1155/2019/1245072. eCollection 2019. Biomed Res Int. 2019. PMID: 31737652 Free PMC article.
-
Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer.J Ovarian Res. 2013 Sep 5;6(1):61. doi: 10.1186/1757-2215-6-61. J Ovarian Res. 2013. PMID: 24007497 Free PMC article.
-
Dissection of a metastatic gene expression signature into distinct components.Genome Biol. 2006;7(12):R117. doi: 10.1186/gb-2006-7-12-r117. Genome Biol. 2006. PMID: 17156469 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources